The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
Johnson & Johnson today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVYtm ...
Measure 114 case in Oregon Supreme Court pits gun ownership tradition against public safety concerns
The Oregon Supreme Court on Thursday questioned whether the historical presence of guns in the state could usurp the public ...
The state argued in favor of the gun control measure, calling it a reasonable response to public safety concerns.
1don MSN
Oregon's long-delayed gun control law, Measure 114, now in the hands of the state supreme court
Oregon Supreme Court justices heard the case Thursday morning, the latest in a long series of court proceedings to determine if the law is constitutional.
State officials are seeking public input on a proposed median added to Route 114 in Danvers and Peabody following several deadly crashes on the state highway in recent years.
The novel Agreement on Climate Change, Trade, and Sustainability balances ambitious environmental targets with domestic ...
The Intelligence Bureau (IB) has released the short notice for the recruitment of 258 vacancies for the post of Assistant ...
Background Although voting is recognised as a social determinant of health, the association between electoral participation ...
10don MSN
Chevron payments make up nearly 24% of Richmond general fund, California city reveals accidentally
Nearly 24% of a California city's general fund comes from payments made by a refinery. That's according to a response to a ...
This news release constitutes a 'Designated News Release' incorporated by reference in the prospectus supplement dated December 9, 2024 to ...
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Caris Life Sciences, Inc. , a leading, patient centric, next-generation AI TechBio company, today reported financial results for the quarter ended September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results